China NT Pharma Group Co. Ltd. Held Extraordinary General Meeting
I'm PortAI, I can summarize articles.
China NT Pharma Group Co. Ltd. held an extraordinary general meeting on January 15, 2026, where shareholders approved the issuance of up to 274,751,679 shares for the acquisition of 100% of Junbinxiongdi Limited, Yuehua Limited, and Zhong He Qun Lian Limited. This acquisition grants control of approximately 58.11% of Zhejiang Kangyuan Medical Device Co., Ltd. All proposals at the meeting were approved.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments